GCP
ANIX icon

GSA Capital Partners’s Anixa Biosciences ANIX Stock Holding History

GSA Capital Partners’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
117,465
+18,623
+19% +$51.8K 0.02% 1248
2026
Q1 		$255K Buy
98,842
+16,724
+20% +$49.5K 0.02% 1336
2025
Q4 		$256K Buy
82,118
+221
+0.3% +$905 0.02% 1257
2025
Q3 		$270K Buy
81,897
+3,790
+5% +$12K 0.02% 1260
2025
Q2 		$258K Buy
78,107
+2,303
+3% +$6.58K 0.02% 1358
2025
Q1 		$217K Buy
+75,804
New +$217K 0.02% 1359

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

GSA Capital Partners's ANIX Position: Q2 2026 in Review

GSA Capital Partners increased its Anixa Biosciences (ANIX) stake by 19% in Q2 2026, buying an estimated $51.8K and bringing the position to 117,465 shares worth $329K. The position accounts for 0.02% of the portfolio, ranked #1248.

GSA Capital Partners first reported a position in ANIX in Q1 2025 and has held it in 6 quarters since. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • GSA Capital Partners held 117,465 shares of Anixa Biosciences worth $329K as of Q2 2026.
  • GSA Capital Partners bought 18,623 Anixa Biosciences shares in Q2 2026, an estimated $51.8K.
  • Anixa Biosciences made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1248 holding.
  • GSA Capital Partners first reported a position in Anixa Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.